Add to MyYahoo RSS

Herceptin, Trastuzumab News

News on Herceptin, Trastuzumab (generic) continually updated from thousands of sources around the net.

Thursday Jul 24 | Seeking Alpha

After Puma's Huge Spike, Is A Potential Acquisition Already Priced In?

Puma jumped nearly 300% due to announcement of a top line breast cancer trial. Puma is now ripe to be acquired.


Related Topix: Medicine, Cancer, Health, Healthcare Law, Law, Breast Cancer, Biotech, Science / Technology, Eli Lilly, Healthcare Industry

Wed Jul 23, 2014

Hispanic Business

Studies from University Hospital Update Current Data on Monoclonal...

Editor at Biotech Week -- Current study results on Drugs and Therapies have been published.


Related Topix: Health, Lung Cancer, Journalism


Branded and Targeted Treatments Driving Almost $4 Billion Growth in...

The increased use of targeted therapies, along with a greater uptake of branded drugs and rising incidence population, will cause the breast cancer therapeutics market value to grow from $9.2 billion in 2013 to $13.1 billion by 2020, says a new report on Breast Cancer Therapeutics in Major Developed Markets to 2020 from Reportstack.


Related Topix: Medicine, Breast Cancer, Health, Cancer

Tue Jul 22, 2014


Puma Biotechnology Announces Positive Top Line Results From Phase III ...

Puma Biotechnology, Inc. , a development stage biopharmaceutical company, announced top line results from the Phase III clinical trial of Puma's investigational drug PB272 for the extended adjuvant treatment of breast cancer .


Related Topix: Medicine, Health, Breast Cancer

Mon Jul 21, 2014

WTHR-TV Indianapolis

Waistlines of U.S. kids seem to be holding steady

New mothers who return to work full-time are less likely to stick with their breast-feeding goals than those who go back to work part-time, a new study finds.


Related Topix: Family, Kids, Medicine, Nursing, Health, Breast Cancer, Heart Failure, Heart Attack

Thu Jul 17, 2014

WTHR-TV Indianapolis

Scientists create 'biological pacemaker' in pig hearts

Researchers say they've found a way to transform ordinary pig heart muscle cells into a "biological pacemaker," a feat that might one day lead to the replacement of electronic pacemakers in humans.


Related Topix: Medicine, Nursing, Alzheimer's

Tue Jul 15, 2014

British Journal of Cancer

HER2-positive advanced breast cancer: optimizing patient outcomes and ...

Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, 160 East 34th Street, New York, NY 10016, USA Effective targeting of the human epidermal growth factor receptor 2 has changed the natural history of HER2 overexpressing metastatic breast cancer.


Related Topix: Medicine, Health, Breast Cancer, Oncology, New York University, San Mateo County, CA, South San Francisco, CA

Sun Jul 06, 2014

Medical News Today

Potential new treatment for aggressive breast cancer

Researchers have discovered a "viable" new target for the treatment of a particularly aggressive form of breast cancer.


Related Topix: Medicine, Health, Breast Cancer, Obstetrics and Gynecology

Fri Jul 04, 2014

PhysOrg Weblog

Significant discovery could tackle spread of breast cancer

For the first time, researchers from Queen Mary University of London have revealed the molecule I vI26 plays a fundamental role in helping breast cancer cells to grow and spread.


Related Topix: Medicine, Breast Cancer, Health

Wed Jul 02, 2014

Hispanic Business

Recent Findings from National Cancer Institute Advance Knowledge in...

To elucidate mechanisms associated with this therapy, targeted ?-particle radiation therapeutic Pb-TCMC-trastuzumab together with paclitaxel was investigated for the treatment of disseminated peritoneal cancers."


Related Topix: Medicine, Dna, Pop/Rock

Tue Jul 01, 2014


Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax

Galena Biopharma, Inc. , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced the notice of allowance of a U.S. Patent for NeuVax covering the use of NeuVax alone or in combination to prevent recurrence of any HER2/neu ... (more)


Related Topix: Biotech, RXi Pharmaceuticals, Oncology, Medicine, Healthcare Law, Law, Food and Drug Administration